US government sets up a way to buy an Alzheimer's diagnostic

The US government awarded a contract to PETNET SOLUTIONS, INC. for a radiopharmaceutical called Amyvid. This means federal healthcare providers now have a specific vendor to acquire this drug, which helps detect amyloid plaques in the brain.

Federal healthcare systems can now easily acquire Amyvid, a drug used in brain scans to detect amyloid plaques. This makes it simpler for doctors in these systems to diagnose conditions like Alzheimer's, though the contract itself does not specify how much will be purchased.